We are pleased to announce our participation at the 11th Annual World Stem Cells & Regenerative Medicine Congress on May 18-20 in London, England. In the past, this event focused on developments in stem cell therapies and innovations within regenerative medicine. As the industry progresses, this year's conference will focus on the cell therapies that have made it to market, the innovations of academia and universities, and the use of stem cells for drug discovery. Additionally, this year's event will be co-located with World Precision Medicine Congress and the Cord Blood World Europe.
From booth #26, Fisher BioServices will showcase our global integrated solution for cell therapy clinical and commercial development. We understand that the success of a cell therapy clinical trial rests on the ability to deliver a viable, potent product. This positive end-result is directly attributable to the strategy in place and the supporting processes. Our team of experts will work with you to develop a reliable cell therapy logistics strategy to ensure your therapy remains viable from the point of manufacture to administration.
If you'd like to schedule a meeting at the event, please do so by completing a Meeting Request form and one of our team members will be in touch. We look forward to discussing some of the challenges you're facing and determining ways to improve your current processes.
To learn more about our cell therapy solutions and how to mitigate the unforeseen challenges associated with scalability, cost, and FDA criteria, download your free eBook Commercially Successful Cell Therapies: Navigating the Ultra Cold Chain Distribution Minefield.